Invention to Startup Forum at ICBI: September 29th at 11am

Thursday, January 1, 1970

Synaptic loss, neuroinflammation and aggregated proteins in the brain are major hallmarks of Alzheimer’s disease (AD).

The Indiana Center for Biomedical Innovation (ICBI) invites you to the “Invention to startup forum”  the topic of discussion “GILZ analogs to suppress neuroinflammation in Alzheimer’s disease”  by Drs. Srinivasan and Lahiri, September 29^nd, 11 am

 

Zoom link:

Topic: Invention to startup forum_september 29th
Time: Sep 29, 2017 11:00 AM Eastern Standard Time (US and Canada)

Join from PC, Mac, Linux, iOS or Android: https://iu.zoom.us/j/266430625

Or Telephone:
Dial: +1 669 900 6833 (US Toll) or +1 646 558 8656 (US Toll)
Meeting ID: 266 430 625
International numbers available: https://iu.zoom.us/zoomconference?m=Pt3WABthrcANZQ–PXjC6Bl0xyLhuTPF

Or connecting from IU videoconferencing equipment:
Video Bridge: 26 266 430 625

Or Skype for Business (Lync):
https://iu.zoom.us/skype/266430625

Zoom@IU Team | cthelp@iu.edu | https://kb.iu.edu/d/bfqu